Management of acute pulmonary embolism

British Journal of Hospital MedicineVol. 76, No. 10 Core TrainingManagement of acute pulmonary embolismRehan Quadery, Charlie A Elliot, Judith Hurdman, David G Kiely, Rhona M Maclean, Ian Sabroe, Joost J van Veen, Robin CondliffeRehan QuaderySearch for more papers by this author, Charlie A ElliotSearch for more papers by this author, Judith HurdmanSearch for more papers by this author, David G KielySearch for more papers by this author, Rhona M MacleanSearch for more papers by this author, Ian SabroeSearch for more papers by this author, Joost J van VeenSearch for more papers by this author, Robin CondliffeSearch for more papers by this authorRehan Quadery; Charlie A Elliot; Judith Hurdman; David G Kiely; Rhona M Maclean; Ian Sabroe; Joost J van Veen; Robin CondliffePublished Online:12 Oct 2015https://doi.org/10.12968/hmed.2015.76.10.C150AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View article References Agnelli G, Buller HR, Cohen A et al. (2013) Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 369(9): 799–808 (doi: https://doi.org/10.1056/NEJMoa1302507) Crossref, Medline, Google ScholarAujesky D, Obrosky DS, Stone RA et al. (2005) Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 172(8): 1041–6 (doi: https://doi.org/10.1164/rccm.200506-862OC) Crossref, Medline, Google ScholarAujesky D, Roy PM, Verschuren F et al. (2011) Outpatient versus inpatient treatmentfor patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 378(9785): 41–8 (doi: https://doi.org/10.1016/S0140-6736(11)60824-6) Crossref, Medline, Google ScholarBath P, Leonardi-Bee J, Bath F (2002) Low molecular weight heparin versus aspirin for acute ischemic stroke: a systematic review. J Stroke Cerebrovasc Dis 11(2): 55–62 (doi: https://doi.org/10.1053/jscd.2002.126694) Crossref, Medline, Google ScholarBuller HR, Prins MH, Lensin AW et al. (2012) Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 366(14): 1287–97 (doi: https://doi.org/10.1056/NEJMoa1113572) Crossref, Medline, Google ScholarCamerlingo M, Salvi P, Belloni G et al. (2005) Intravenous heparin started within the first 3 hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions. Stroke 36(11): 2415–20 (doi: https://doi.org/10.1161/01.STR.0000185730.50480.e7) Crossref, Medline, Google ScholarChatterjee S, Chakraborti A, Weinberg I et al. (2014) Thrombolysis for pulmonary embolism and risk for all-cause mortality, major bleeding and intracranial hemorrhage. A meta-analysis. JAMA 311(23): 2414–21 (doi: https://doi.org/10.001/JAMA.2014.5990) Crossref, Medline, Google ScholarCondliffe R, Elliot C, Hughes R et al. (2013) Management dilemmas in acute pulmonary embolism. Thorax 69(2): 174–80 (doi: https://doi.org/10.1136/thoraxjnl-2013-204667) Crossref, Medline, Google ScholarInternational Stroke Trial Collaborative Group (1997) The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349(9065): 1569–81 (doi: https://doi.org/10.1016/S0140-6736(97)04011-7) Crossref, Medline, Google ScholarJaff MR, McMurtry MS, Archer SL et al. (2011) Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 123(6): 1788–830 Crossref, Medline, Google ScholarKearon C, Akl EA, Comerota AJ et al. (2012) Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2): e419S–94S Crossref, Medline, Google ScholarKonstantinides S, Geibel A, Heusel G et al. (2002) Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 347(15): 1143–50 (doi: https://doi.org/10.1056/NEJMoa021274) Crossref, Medline, Google ScholarKronik G (1989) The European Cooperative Study on the clinical significance of right heart thrombi. European Working Group on Echocardiography. Eur Heart J 10(12): 1046–59 Medline, Google ScholarMeyer G, Vicaut E, Danays T et al., PEITHO Investigators (2014) Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 370(15): 1402–11 (doi: https://doi.org/10.1056/NEJMoa1302097) Crossref, Medline, Google ScholarMismetti P, Laporte S, Pellerin O et al. (2015) Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA 313(16): 1627–35 (doi: https://doi.org/10.1001/jama.2015.3780) Crossref, Medline, Google ScholarNational Institute for Health and Care Excellence (2012) Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing. (www.nice.org.uk/guidance/cg144 accessed 13 July 2015) Google ScholarPREPIC Study Group (2005) Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation 112(3): 416–22 (doi: https://doi.org/10.1161/CIRCULATIONAHA.104.512834) Crossref, Medline, Google ScholarPiccioli A, Lensing A, Prins M et al. (2004) Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial. J Thromb Haemost 2(6): 884–9 Crossref, Medline, Google ScholarSharifi M, Bay C, Skrocki L et al. (2013) Moderate pulmonary embolism treated with thrombolysis (from the ‘MOPETT’ Trial). Am J Cardiol 111(2): 273–7 (doi: https://doi.org/10.1016/j.amjcard.2012.09.027) Crossref, Medline, Google ScholarShaul WL, Hall JG (1997) Multiple congenital anomalies associated with oral anticoagulants. Am J Obstet Gynecol 127(2): 191–8 Google ScholarTodoran TM, Sobieszczyk P (2010) Catheter-based therapies for massive pulmonary embolism. Prog Cardiovasc Dis 52(2): 429–37 (doi: https://doi.org/10.1016/j.pcad.2010.01.002) Crossref, Medline, Google ScholarTorbicki A, Galie N, Covezzoli A et al. (2003) Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry. J Am Coll Cardiol 41(12): 2245–51 (doi: https://doi.org/10.1016/S0735-1097(03)00479-0) Crossref, Medline, Google ScholarTorbicki A, Agnelli G, Danchin N et al. (2014) ESC Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 35(43): 3033–69 (doi: https://doi.org/10.1093/eurheartj/ehu283) Crossref, Medline, Google Scholarvan Doormaal FF, Terpstra W, Van Der Griend R et al. (2011) Is extensive screening for cancer in idiopathic venous thromboembolism warranted? J Thromb Haemost 9: 79–84 (doi: https://doi.org/10.1056/NEJMoa1506623) Crossref, Medline, Google ScholarVanni S, Viviani G, Baioni M et al. (2013) Prognostic value of plasma lactate levels among patients with acute pulmonary embolism: the thrombo-embolism lactate outcome study. Ann Emerg Med 61(3): 330–8 (doi: https://doi.org/10.1016/j.annemergmed.2012.10.022) Crossref, Medline, Google Scholar FiguresReferencesRelatedDetailsCited byPathways for outpatient management of venous thromboembolism in a UK centre5 December 2016 | Thrombosis Journal, Vol. 14, No. 1Is Routine Thromboprophylaxis Needed in Korean Patients Undergoing Unicompartmental Knee Arthroplasty?Journal of Korean Medical Science, Vol. 31, No. 3 2 October 2015Volume 76Issue 10ISSN (print): 1750-8460ISSN (online): 1759-7390 Metrics History Published online 12 October 2015 Published in print 2 October 2015 Information© MA Healthcare LimitedPDF download